This is a preview of subscription content, log in via an institution to check access.
Reference
Bagai A, et al. Clinical outcomes and cost implications of routine early PCI after fibrinolysis: One-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study. American Heart Journal 165: 630-637, No. 4, Apr 2013. Available from: URL: http://dx.doi.org/10.1016/j.ahj.2012.12.016
Additional information
* coronary artery bypass grafting
** Costs included those associated with hospitalisation, drug acquisition including GP IIb/IIIa inhibitors such as abciximab or eptifibatide, procedures and investigations, transportation by land or air, PCI and CABG as well the treatment of events during follow-up such as MI or recurrent ischaemia.
Rights and permissions
About this article
Cite this article
Early PCI after fibrinolysis in STEMI worth it at "modest" cost. PharmacoEcon Outcomes News 677, 6 (2013). https://doi.org/10.1007/s40274-013-0354-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0354-1